QGEN Qiagen NV

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024.

Press release date / time: Wednesday, July 31, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Thursday, August 1, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.

Three options for joining the conference call

Register for call back connection - Click here: Connect meService is available 15 minutes before the call starts

Dial-in by phone U.S.: +1 646 828 8193UK: +44 (0)330 165 3655GER: +49 (0)69 6610 2492Conference ID: 8081810To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.

Access the audio webcast - Click here: Access Webcast

A conference call replay will be available by using the following link: https://event.webcasts.com/starthere.jsp?ei=1643476&tp_key=e15f4dcc6b

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sampleto Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these togetherin seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in the Life Sciences (academia, pharma R&D and industrial applications, primarily forensic) and Molecular Diagnostics (human healthcare). As of March 31, 2024, QIAGEN employed 6,000 people in over 35 locations worldwide.Further information can be found at http://www.qiagen.com.

source: QIAGEN N.V.category: Financial

John Gilardi
QIAGEN N.V. 
+49 152 018 11711
ir@qiagen.com

Domenica Martorana
QIAGEN N.V. 
+49 152 018 11244
ir@qiagen.com